Cold War, Hot Mess | VQR Online vqronline.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vqronline.org Daily Mail and Mail on Sunday newspapers.
(1)
Berwyn, Pennsylvania (Newsfile Corp. - July 28, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ( Annovis or the Company ), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, with data from two phase 2 studies showing its lead compound improves cognition in AD patients and motor function in PD patients, is presenting new clinical efficacy and biomarker data of its drug ANVS401 during a one hour panel presentation, beginning at 8:00 p.m. ET today, July 28, at the 2021 Alzheimer s Association International Conference (AAIC) in Denver, Colorado.
The first part of the panel will feature Cheng Fang, PhD, Annovis Bio s VP of Research, an expert in axonal transport and protein aggregation. Dr. Fang will present the mechanism of action and will be followed by William Mobley, PhD, Distinguished Professor, Department of Neurosciences, and the Florence Riford Chair for Alzheimer s Research at the Un
Social Justice as Part of the Remedy for What Ails Us New center in Sanford Institute for Empathy and Compassion focuses on issues in health care June 03, 2021 | Scott LaFee; Mario Aguilera
News release
Eliminating racial inequity demands empathy and compassion, but also social justice.
The newest center within the T. Denny Sanford Institute for Empathy and Compassion at UC San Diego will have that focus, created to identify, understand and resolve social justice issues in health care that primarily affect racial and ethnic minorities, women, LGBTQ and under-privileged communities.
“Across this country and throughout society, we face extraordinary challenges regarding racial injustice, especially those impacting marginalized members of our communities,” said Gentry Patrick, PhD, a professor of neurobiology in the Division of Biological Sciences and the newly named director of the Center for Empathy and Social Justice in Human Health within the Sanford In
Tillery
BELLEVILLE – St. Clair County Associate Judge Kevin Hoerner entered nine straight orders in favor of paraquat plaintiffs in preparation for a trial he would have started Monday, May 10.
The parties asked for a delay over the weekend, and Hoerner granted it.
In rulings from May 3 to May 6, he limited testimony of 17 defense experts and entirely excluded two.
He denied all defense motions for limits on testimony.
Farmers Carroll Rowan, Jerry Mills, Freemon Schmidt, and Ronald Niebrugge claim they suffer Parkinson’s disease from using paraquat to control weeds.
They seek damages from Syngenta Crop Protection and Growmark cooperative as suppliers, and Chevron USA as manufacturer.
(1)
Collaborative mice study with UC San Diego to study brain development from embryo to old age
Berwyn, Pennsylvania (Newsfile Corp. - April 29, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, today announced a new research collaboration with Professor William Mobley and Dr. Xuqiao Chen at the University of California San Diego designed to study the ability of the Company s lead compound, ANVS401, to normalize brain development in Down Syndrome (DS) mice. While we know quite a bit about how the brain degenerates in the later stages of life, extraordinarily little is known about how neurodegeneration may start very early in life. We, therefore, plan to look at the brain in embryonic development in DS mice, said Maria Maccecchini, Ph.D., Founder and Chief Executive Officer.